Nutritional Therapy

  • Wael El Matary
  • Mary Zachos


Inflammatory Bowel Disease Enteral Nutrition Crohn Disease Nutritional Therapy Mucosal Healing 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Griffiths, A., Inflammatory Bowel Disease; Chapter 41; Pediatric Gastrointestinal Disease. 3rd ed, ed. W.A.D.P.H.J.e. al. 2000, Hamilton: BC Decker.Google Scholar
  2. 2.
    Seidman, E., et al., Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 1991. 12(4): 424–38.Google Scholar
  3. 3.
    Kanof, M.E., A.M. Lake, and T.M. Bayless, Decreased height velocity in children and adolescents before the diagnosis of Crohn disease. Gastroenterology, 1988. 95(6):1523–7.PubMedGoogle Scholar
  4. 4.
    Levine, A., et al., Consensus and controversy in the management of pediatric Crohn disease: an international survey. J Pediatr Gastroenterol Nutr, 2003. 36(4): 464–9.PubMedCrossRefGoogle Scholar
  5. 5.
    Kelts, D.G., et al., Nutritional basis of growth failure in children and adolescents with Crohn disease. Gastroenterology, 1979. 76(4): 720–7.Google Scholar
  6. 6.
    Kirschner, B.S., et al., Reversal of growth retardation in Crohn disease with therapy emphasizing oral nutritional restitution. Gastroenterology, 1981. 80(1): 10–5.Google Scholar
  7. 7.
    Kirschner, B.S., O. Voinchet, and I.H. Rosenberg, Growth retardation in inflammatory bowel disease. Gastroenterology, 1978. 75(3): 504–11.PubMedGoogle Scholar
  8. 8.
    Motil, K.J., S.I. Altchuler, and R.J. Grand, Mineral balance during nutritional supplementation in adolescents with Crohn disease and growth failure. J Pediatr, 1985. 107(3): 473–9.PubMedCrossRefGoogle Scholar
  9. 9.
    Motil, K.J., et al., The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure. J Pediatr, 1982. 101(3): 345–51.PubMedCrossRefGoogle Scholar
  10. 10.
    Azcue, M., et al., Energy expenditure and body composition in children with Crohn disease: effect of enteral nutrition and treatment with prednisolone. Gut, 1997. 41(2): 203–8.PubMedGoogle Scholar
  11. 11.
    Zoli, G., et al., Effect of oral elemental diet on nutritional status, intestinal permeability and disease activity in Crohn patients. Gastroenterology, 1996. 110(4): A1054.Google Scholar
  12. 12.
    Thomas, A.G., F. Taylor, and V. Miller, Dietary intake and nutritional treatment in childhood Crohn disease. J Pediatr Gastroenterol Nutr, 1993. 17(1): 75–81.PubMedGoogle Scholar
  13. 13.
    Trebble, T.M., et al., Essential fatty acid status in paediatric Crohn disease relationship with disease activity and nutritional status. Aliment Pharmacol Ther, 2003. 18(4): 433–42.Google Scholar
  14. 14.
    Driscoll, R.H., Jr., et al., Vitamin D deficiency and bone disease in patients with Crohn disease. Gastroenterology, 1982. 83(6): 1252–8.PubMedGoogle Scholar
  15. 15.
    Geerling, B.J., et al., Comprehensive nutritional status in patients with long-standing Crohn disease currently in remission. Am J Clin Nutr, 1998. 67(5): 919–26.Google Scholar
  16. 16.
    Schoon, E.J., et al., Low serum and bone vitamin K status in patients with longstanding Crohn disease: another pathogenetic factor of osteoporosis in Crohn disease? Gut, 2001. 48(4): 473–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Kleinman, R.E., et al., Nutrition support for pediatric patients with inflammatory bowel disease: a clinical report of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr, 2004. 39(1): 15–27.PubMedCrossRefGoogle Scholar
  18. 18.
    Kleinman, R.E., et al., Nutritional support for pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr, 1989. 8(1): 8–12.PubMedGoogle Scholar
  19. 19.
    Sondike, S., Weight status in pediatric IBD patients at the time of diagnosis: effects of the obesity epidemic. J Pediatr Gastroenterol Nutr, 2004. 39(Suppl 1): S317.Google Scholar
  20. 20.
    Blain, A., et al., Crohn disease clinical course and severity in obese patients. Clin Nutr,2002. 21(1): 51–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Gokhale, R., et al., Bone mineral density assessment in children with inflammatory bowel disease. Gastroenterology, 1998. 114(5): 902–11.PubMedCrossRefGoogle Scholar
  22. 22.
    Compston, J.E., Management of bone disease in patients on long term glucocorticoid therapy. Gut, 1999. 44(6): 770–2.PubMedCrossRefGoogle Scholar
  23. 23.
    Hyams, J.S. and D.E. Carey, Corticosteroids and growth. J Pediatr, 1988. 113(2): 249–54.PubMedCrossRefGoogle Scholar
  24. 24.
    Franklin, J.L. and H.H. Rosenberg, Impaired folic acid absorption in inflammatory bowel disease: effects of salicylazosulfapyridine (Azulfidine). Gastroenterology, 1973. 64(4): 517–25.PubMedGoogle Scholar
  25. 25.
    Feagan, B.G., et al., Methotrexate for the treatment of Crohn disease. The North American Crohn Study group investigators. N Engl J Med, 1995. 332(5): 292–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Fridge, J., The specific carbohydrate diet – a treatment for Crohn disease? J Pediatr Gastroenterol Nutr, 2004. 39(Suppl 1): S299.Google Scholar
  27. 27.
    Ritchie, J.K., et al., Controlled multicentre therapeutic trial of an unrefined carbohydrate, fibre rich diet in Crohn disease. Br Med J (Clin Res Ed), 1987. 295(6597): 517–20.CrossRefGoogle Scholar
  28. 28.
    Levenstein, S., et al., Low residue or normal diet in Crohn disease: a prospective controlled study in Italian patients. Gut, 1985. 26(10): 989–93.PubMedCrossRefGoogle Scholar
  29. 29.
    Griffiths, A.M., Inflammatory bowel disease. Nutrition, 1998. 14(10): 788–91.PubMedCrossRefGoogle Scholar
  30. 30.
    Voitk, A.J., et al., Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg, 1973. 107(2): 329–33.PubMedGoogle Scholar
  31. 31.
    O’Morain, C.A., A.W. Segal, and A.J. Levi, Elemental diet as primary treatment of acute Crohn disease: a controlled trial. Br Med J (Clin Res Ed), 1984. 288(6434): 1859–62.Google Scholar
  32. 32.
    Gorard, D.A., et al., Initial response and subsequent course of Crohn disease treated with elemental diet or prednisolone. Gut, 1993. 34(9): 1198–202.PubMedCrossRefGoogle Scholar
  33. 33.
    Lindor, K.D., et al., A randomized prospective trial comparing a defined formula diet, corticosteroids, and a defined formula diet plus corticosteroids in active Crohn disease. Mayo Clin Proc, 1992. 67(4): 328–33.PubMedGoogle Scholar
  34. 34.
    Lochs, H., et al., Comparison of enteral nutrition and drug treatment in active Crohn disease. Results of the European Cooperative Crohn Disease Study. IV. Gastroenterology, 1991. 101(4): 881–8.PubMedGoogle Scholar
  35. 35.
    Malchow, H., et al., European cooperative Crohn disease study (ECCDS): results of drug treatment. Gastroenterology, 1984. 86(2): 249–66.PubMedGoogle Scholar
  36. 36.
    Sanderson, I.R., et al., Remission induced by an elemental diet in small bowel Crohn disease. Arch Dis Child, 1987. 62(2): 123–7.PubMedGoogle Scholar
  37. 37.
    Seidman, E.G., et al., Semi-elemental diet versus prednisone in pediatric Crohn disease. Gastroenterology, 1993. 104: A778.Google Scholar
  38. 38.
    Seidman, E.G., et al., Elemental diet versus prednisone as initial therapy in Crohn disease: early and long-term results. Gastroenterology, 1991. 100: 150A.Google Scholar
  39. 39.
    Zachos, M., M. Tondeur, and A.M. Griffiths, Enteral nutritional therapy for induction of remission in Crohn disease. Cochrane Database Syst Rev, 2007. (1): CD000542.Google Scholar
  40. 40.
    Fernandez-Banares, F., et al., How effective is enteral nutrition in inducing clinical remission in active Crohn disease? A meta-analysis of the randomized clinical trials. J Parenter Enteral Nutr, 1995. 19: 1056–64.Google Scholar
  41. 41.
    Messori, A., et al., Defined-formula diets versus steroids in the treatment of active Crohn disease. A Meta-analysis. Scand J Gastroenterol, 1996. 31: 267–72.Google Scholar
  42. 42.
    Borrelli, O., et al., Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol, 2006. 4(6): 744–53.PubMedCrossRefGoogle Scholar
  43. 43.
    Jadad, A.R., et al., Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials, 1996. 17(1): 1–12.PubMedCrossRefGoogle Scholar
  44. 44.
    Gonzalez-Huix, F., et al., Polymeric enteral diets as primary treatment of active Crohn disease: a prospective steroid controlled trial. Gut, 1993. 34(6): 778–82.PubMedCrossRefGoogle Scholar
  45. 45.
    Heuschkel, R.B., et al., Enteral nutrition and corticosteroids in the treatment of acute Crohn disease in children. J Pediatr Gastroenterol Nutr, 2000. 31(1): 8–15.PubMedCrossRefGoogle Scholar
  46. 46.
    Beattie, R.M., et al., Polymeric nutrition as the primary therapy in children with small bowel Crohn disease. Aliment Pharmacol Ther, 1994. 8(6): 609–15.PubMedCrossRefGoogle Scholar
  47. 47.
    Fell, J.M.E., et al., Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn disease. Aliment Pharmacol Ther, 2000. 14: 281–9.PubMedCrossRefGoogle Scholar
  48. 48.
    O’Sullivan, M.A. and C.A. O’Morain, Nutritional therapy in Crohn disease. Inflamm Bowel Dis, 1998. 4(1): 45–53.PubMedCrossRefGoogle Scholar
  49. 49.
    Akobeng, A.K., et al., Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn disease. J Pediatr Gastroenterol Nutr, 2000. 30(1): 78–84.PubMedCrossRefGoogle Scholar
  50. 50.
    Bamba, T., et al., Dietary fat attenuates the benefits of an elemental diet in active Crohn disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol, 2003. 15(2): 151–7.PubMedCrossRefGoogle Scholar
  51. 51.
    Gassull, M.A., et al., Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn disease: results of a double blind randomised multicentre European trial. Gut, 2002. 51(2): 164–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Leiper, K., et al., A randomised controlled trial of high versus low long chain triglyceride whole protein feed in active Crohn disease. Gut, 2001. 49(6): 790–4.PubMedCrossRefGoogle Scholar
  53. 53.
    Sakurai, T., et al., Short-term efficacy of enteral nutrition in the treatment of active Crohn disease: a randomized, controlled trial comparing nutrient formulas. J Parenter Enteral Nutr, 2002. 98–103.Google Scholar
  54. 54.
    Johnson, T., et al., Treatment of active Crohn disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut, 2006. 55(3): 356–61.PubMedCrossRefGoogle Scholar
  55. 55.
    Seidman, E., Relapse prevention/growth enhancement in pediatric Crohn disease: multicentre randomized controlled trial of intermittent enteral nutrition versus alternate day prednisone. J Pediatr Gastroenterol Nutr, 1996. 23: A344.Google Scholar
  56. 56.
    Day, A.S., et al., Exclusive enteral feeding as primary therapy for Crohn disease in Australian children and adolescents: a feasible and effective approach. J Gastroenterol Hepatol, 2006. 21(10): 1609–14.PubMedCrossRefGoogle Scholar
  57. 57.
    Esaki, M., et al., Factors affecting recurrence in patients with Crohn disease under nutritional therapy. Dis Colon Rectum, 2006. 49(10 Suppl): S68–74.PubMedCrossRefGoogle Scholar
  58. 58.
    Knight, C., et al., Long-term outcome of nutritional therapy in paediatric Crohn disease. Clin Nutr, 2005. 24(5): 775–9.PubMedCrossRefGoogle Scholar
  59. 59.
    Afzal, N.A., et al., Colonic Crohn disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci, 2005. 50(8): 1471–5.PubMedCrossRefGoogle Scholar
  60. 60.
    Breese, E.J., et al., Tumor necrosis factor alpha-producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology, 1994. 106(6): 1455–66.PubMedGoogle Scholar
  61. 61.
    Breese, E.J., et al., The effect of treatment on lymphokine-secreting cells in the intestinal mucosa of children with Crohn disease. Aliment Pharmacol Ther, 1995. 9(5): 547–52.PubMedCrossRefGoogle Scholar
  62. 62.
    Berni Canani, R., et al., Short- and long-term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn disease. Dig Liver Dis, 2006. 38(6): 381–7.PubMedCrossRefGoogle Scholar
  63. 63.
    Royall, D., et al., Total enteral nutrition support improves body composition of patients with active Crohn disease. JPEN J Parenter Enteral Nutr, 1995. 19(2): 95–9.PubMedGoogle Scholar
  64. 64.
    Bannerjee, K., et al., Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr, 2004. 38(3): 270–5.PubMedCrossRefGoogle Scholar
  65. 65.
    Teahon, K., et al., Alterations in nutritional status and disease activity during treatment of Crohn disease with elemental diet. Scand J Gastroenterol, 1995. 30(1): 54–60.PubMedGoogle Scholar
  66. 66.
    Papadopoulou, A., et al., Remission following an elemental diet or prednisolone in Crohn disease. Acta Paediatr, 1995. 84(1): 79–83.PubMedGoogle Scholar
  67. 67.
    Gailhoustet, L., et al., Study of psychological repercussions of 2 modes of treatment of adolescents with Crohn disease. Arch Pediatr, 2002. 9(2): 110–6.PubMedCrossRefGoogle Scholar
  68. 68.
    Afzal, N.A., et al., Improvement in quality of life of children with acute Crohn disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther, 2004. 20(2): 167–72.PubMedCrossRefGoogle Scholar
  69. 69.
    Rigaud, D., et al., Controlled trial comparing two types of enteral nutrition in treatment of active Crohn disease: elemental versus polymeric diet. Gut, 1991. 32(12): 1492–7.PubMedCrossRefGoogle Scholar
  70. 70.
    Wilschanski, M., et al., Supplementary enteral nutrition maintains remission in paediatric Crohn disease. Gut, 1996. 38(4): 543–8.PubMedCrossRefGoogle Scholar
  71. 71.
    Verma, S., et al., Oral nutritional supplementation is effective in the maintenance of remission in Crohn disease. Dig Liver Dis, 2000. 32(9): 769–74.PubMedCrossRefGoogle Scholar
  72. 72.
    Takagi, S., et al., Effectiveness of an ‘half elemental diet’ as maintenance therapy for Crohn disease: A randomized-controlled trial. Aliment Pharmacol Ther, 2006. 24(9): 1333–40.PubMedCrossRefGoogle Scholar
  73. 73.
    Belli, D.C., et al., Chronic intermittent elemental diet improves growth failure in children with Crohn disease. Gastroenterology, 1988. 94(3): 603–10.PubMedGoogle Scholar
  74. 74.
    Seidman, E., Cyclical exclusive enteral nutrition versus alternative day prednisone in maintaining remission in pediatric Crohn disease. J Pediatr Gastroenterol Nutr, 1996. 23: A334.CrossRefGoogle Scholar
  75. 75.
    Yamamoto, T., et al., Impact of long-term enteral nutrition on clinical and endoscopic recurrence after resection for Crohn disease: A prospective, non-randomized, parallel, controlled study. Aliment Pharmacol Ther, 2007. 25(1): 67–72.PubMedCrossRefGoogle Scholar
  76. 76.
    Tanaka, T., et al., Effect of concurrent elemental diet on infliximab treatment for Crohn disease. J Gastroenterol Hepatol, 2006. 21(7): 1143–9.PubMedCrossRefGoogle Scholar
  77. 77.
    Kuroki, F., T. Matsumoto, and M. Iida, Selenium is depleted in Crohn disease on enteral nutrition. Dig Dis, 2003. 21(3): 266–70.PubMedCrossRefGoogle Scholar
  78. 78.
    Akobeng, A.K., et al., Effect of exclusive enteral nutritional treatment on plasma antioxidant concentrations in childhood Crohn disease. Clin Nutr, 2007. 26(1): 51–6.PubMedCrossRefGoogle Scholar
  79. 79.
    Afzal, N.A., et al., Refeeding syndrome with enteral nutrition in children: a case report, literature review and clinical guidelines. Clin Nutr, 2002. 21(6): 515–20.PubMedCrossRefGoogle Scholar
  80. 80.
    Ruemmele, F.M., et al., Nutrition as primary therapy in pediatric Crohn disease: fact or fantasy? J Pediatr, 2000. 136(3): 285–91.PubMedCrossRefGoogle Scholar
  81. 81.
    Gorard, D.A., Enteral nutrition in Crohn disease: fat in the formula. European J Gastroenterol Hepatol, 2003. 15: 115–8.CrossRefGoogle Scholar
  82. 82.
    Whiting, C.V., P.W. Bland, and J.F. Tarlton, Dietary n-3 polyunsaturated fatty acids reduce disease and colonic proinflammatory cytokines in a mouse model of colitis. Inflamm Bowel Dis, 2005. 11(4): 340–9.PubMedCrossRefGoogle Scholar
  83. 83.
    Sanderson, I.R. and N.M. Croft, The anti-inflammatory effects of enteral nutrition. JPEN J Parenter Enteral Nutr, 2005. 29(Suppl 4): S134–8; discussion S138–40, S184–8.PubMedGoogle Scholar
  84. 84.
    Shanahan, F., Host-flora interactions in inflammatory bowel disease. Inflamm Bowel Dis, 2004. 10(Suppl 1): S16–24.PubMedCrossRefGoogle Scholar
  85. 85.
    Lionetti, P., et al., Enteral nutrition and microflora in pediatric Crohn disease. JPEN J Parenter Enteral Nutr, 2005. 29(4 Suppl): S173–5; discussion S175–8, S184–8.PubMedGoogle Scholar
  86. 86.
    Eng WR, D.A., Leach S, et al., Exclusive enteral nutrition alters the intestinal microbiota of children with Crohn disease. Gastroenterology, 2005. 128: A511.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Wael El Matary
    • 1
  • Mary Zachos
    • 2
  1. 1.Division of Gastroenterology –Department of Pediatrics, Stollery Children’s HospitalUniversity of AlbertaEdmonton, AlbertaCanada
  2. 2.Department of PediatricsUniversity of Toronto, Clinical Director – Inflammatory Bowel Disease program, Staff Gastroenterologist, Hospital for Sick Children, The Hospital for Sick ChildrenTorontoCanada

Personalised recommendations